Oberarzt

Dr. med. Marc Andrea

PositionOberarzt
FacharztFacharzt für Innere Medizin und Hämatologie und Onkologie
EinrichtungHämatologie und internistische Onkologie

Kurzvita

  • 2013 Studium der Humanmedizin an der Medizinischen Fakultät Leipzig

Forschung & Lehre

  • Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with newly diagnosed/untreated multiple myeloma

  • Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myelomaandlight chain induced renal failure

  • Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma:results of a phase2 clinicaltrial (OSHO-#077)

  • Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients underfirst-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)

  • Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma

  • Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV)

  • Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advancedrenalfailure using bortezomib in combination with bendamustine and prednisone

Kliniken

  • Asklepios Klinik Weissenfels

    Hämatologie und internistische Onkologie

    Naumburger Straße 76
    06667 Weißenfels

    +49 3443 40 1935

    Zur Abteilung
  • Center of Excellence / Exzellenzzentrum, Akutklinik, Akad. Lehrkrankenhaus, Wiss. Aktivitäten

    Asklepios Klinik Weissenfels

    Naumburger Straße 76
    06667 Weißenfels

    (0 34 43) 40-0

    Zur Einrichtung